Functional mononucleotide repeat polymorphism in the promoter region of HGF is associated with risk and malignant aggressiveness of bladder cancer

International Journal of Oncology

Volumn 44, Issue 3, 2014, Pages 678-684

  Chiba, Syuji ^a   Tsuchiya, Norihiko ^a,b   Horikawa, Yohei ^a   Narita, Shintaro ^a,b   Inoue, Takamitsu ^a,b   Akihama, Susumu ^a   Saito, Mitsuru ^a   Numakura, Kazuyuki ^a   Tsuruta, Hiroshi ^a   Huang, Mingguo ^a,b   Satoh, Shigeru ^a   Habuchi, Tomonori ^a,b  

^a AKITA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Bladder cancer; Deoxyadenosine tract element; Hepatocyte growth factor

Indexed keywords

DEOXYADENOSINE; DEOXYADENOSINE TRACT ELEMENT; MESSENGER RNA; SCATTER FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; DNA SEQUENCE; FEMALE; FUNCTIONAL MONONUCLEOTIDE REPEAT POLYMORPHISM; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS, GENETIC; RISK FACTORS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84896716204     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2221     Document Type: Article

References (23)

1. Trusolino L and Comoglio PM: Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer 2: 289-300, 2002. (Pubitemid 37328782)
2. Birchmeier C, Birchmeier W, Gherardi E and Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925, 2003. (Pubitemid 37493640)
3. Aune G, Lian AM, Tingulstad S, Torp SH, Forsmo S, Reseland JE, Stunes AK and Syversen U: Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis. Gynecol Oncol 121: 402-406, 2011.
4. Gohji K, Nomi M, Niitani Y, Kitazawa S, Fujii A, Katsuoka Y and Nakajima M: Independent prognostic value of serum hepatocyte growth factor in bladder cancer. J Clin Oncol 18: 2963-2971, 2000. (Pubitemid 30644120)
5. Saigusa S, Toiyama Y, Tanaka K, Yokoe T, Fujikawa H, Matsushita K, Okugawa Y, Inoue Y, Uchida K, Mohri Y and Kusunoki M: Inhibition of HGF/cMET expression prevents distant recurrence of rectal cancer after preoperative chemoradiotherapy. Int J Oncol 40: 583-591, 2012.
6. Wu CW, Li AF, Chi CW, Chung WW, Liu TY, Lui WY and P'Eng FK: Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma. Oncol Rep 5: 817-822, 1998.
7. Ueki T, Fujimoto J, Suzuki T, Yamamoto H and Okamoto E: Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 25: 862-866, 1997. (Pubitemid 27157127)
8. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T and Shin S: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54: 1630-1633, 1994. (Pubitemid 24116158)
9. Bharti A, Ma PC, Maulik G, Singh R, Khan E, Skarin AT and Salgia R: Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Anticancer Res 24: 1031-1038, 2004. (Pubitemid 38624933)
10. Coskun U, Bukan N, Sancak B, Gunel N, Ozenirler S, Unal A and Yucel A: Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions. Neoplasma 51: 209-213, 2004. (Pubitemid 38821501)
11. Toiyama Y, Miki C, Inoue Y, Okugawa Y, Tanaka K and Kusunoki M: Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients. Int J Cancer 125: 1657-1662, 2009. (Pubitemid 44441370)
12. Tanimoto S, Fukumori T, El-Moula G, Shiirevnyamba A, Kinouchi S, Koizumi T, Nakanishi R, Yamamoto Y, Taue R, Yamaguchi K, Nakatsuji H, Kishimoto T, et al: Prognostic significance of serum hepatocyte growth factor in clear cell renal cell carcinoma: comparison with serum vascular endothelial growth factor. J Med Invest 55: 106-111, 2008. (Pubitemid 351643600)
13. Chau GY, Lui WY, Chi CW, Chau YP, Li AF, Kao HL and Wu CW: Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection. Eur J Surg Oncol 34: 333-338, 2008.
14. Ma J, DeFrances MC, Zou C, Johnson C, Ferrell R and Zarnegar R: Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer. J Clin Invest 119: 478-491, 2009.
15. Shimizu M, Mori T, Sakurai T and Shindo H: Destabilization of nucleosomes by an unusual DNA conformation adopted by poly(dA) small middle dotpoly(dT) tracts in vivo. EMBO J 19: 3358-3365, 2000. (Pubitemid 30428213)
16. Koch KA and Thiele DJ: Functional analysis of a homopolymeric (dA-dT) element that provides nucleosomal access to yeast and mammalian transcription factors. J Biol Chem 274: 23752-23760, 1999. (Pubitemid 29390297)
17. Fox KR: Wrapping of genomic polydA.polydT tracts around nucleosome core particles. Nucleic Acids Res 20: 1235-1242, 1992.
18. Iyer V and Struhl K: Poly(dA:dT), a ubiquitous promoter element that stimulates transcription via its intrinsic DNA structure. EMBO J 14: 2570-2579, 1995.
19. Anderson JD and Widom J: Poly(dA-dT) promoter elements increase the equilibrium accessibility of nucleosomal DNA target sites. Mol Cell Biol 21: 3830-3839, 2001. (Pubitemid 32466994)
20. Reardon BJ, Winters RS, Gordon D and Winter E: A peptide motif that recognizes A.T tracts in DNA. Proc Natl Acad Sci USA 90: 11327-11331, 1993. (Pubitemid 23354422)
21. Graziano F, Galluccio N, Lorenzini P, Ruzzo A, Canestrari E, D'Emidio S, Catalano V, Sisti V, Ligorio C, Andreoni F, Rulli E, Di Oto E, et al: Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer. J Clin Oncol 29: 4789-4795, 2011.
22. Lopez-Beltran A and Montironi R: Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol 46: 170-176, 2004. (Pubitemid 38902731)
23. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: Urinary bladder. In: AJCC Cancer Staging Manual. 7th edition. Springer, New York, NY, pp497-505, 2010.